Sarepta Gene Therapy Suspension - Search News

Order byBest matchMost fresh

News

Roche pauses Sarepta gene therapy shipments outside U.S.

· 1h · on MSN

What’s behind Sarepta’s gene therapy deaths?

Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral vector used in the drugs. Read more here.

Continue reading

· 3d · on MSN

In a reversal, Sarepta says it will pause shipments of gene therapy linked to deaths

Devdiscourse · 4d

Sarepta Suspends Gene Therapy Shipments After Tragic Deaths

Precision Medicine Online2d

Sarepta Halts Duchenne Gene Therapy Sales Amid FDA Scrutiny, Raising Concerns Over Financial Future

Wall Street analysts warn that if Sarepta Therapeutics doesn't resolve the Elevidys issues, it could jeopardize its ability to repay debt in 2027.

11don MSN

Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients

Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best low priced pharma stocks to buy now. Towards the end of June, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results